Prediction of outcomes for high-count monoclonal B lymphocytosis using an epigenetic and immunogenetic signature. Abdelbaky SB, Giacopelli B, Rabe KG, Yamaguchi K, et al. Blood 2024;143:1752-1757.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Abdelbaky SB, Giacopelli B, Rabe KG, Yamaguchi K, et al. Prediction of outcomes for high-count monoclonal B lymphocytosis using an epigenetic and immunogenetic signature. Blood 2024;143:1752-1757.
PMID: 38194687